Tumor microenvironment and nanotherapeutics. - Wikidata - awgldk - TriplyDB

Tumor microenvironment and nanotherapeutics.

Tumor microenvironment and nanotherapeutics.

http://www.wikidata.org/entity/Q37632757

about

Convergence of nanotechnology and cancer prevention: are we there yet?Maytansine-loaded star-shaped folate-core PLA-TPGS nanoparticles enhancing anticancer activity Nanopharmacology in translational hematology and oncology An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids.Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor Microenvironment Barriers to drug delivery in solid tumors.Targeting mitochondria in cancer cells using gold nanoparticle-enhanced radiotherapy: a Monte Carlo study.Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer.Characterization of Polyelectrolyte Complex Formation Between Anionic and Cationic Poly(amino acids) and Their Potential Applications in pH-Dependent Drug Delivery.Exosomes released from pancreatic cancer cells enhance angiogenic activities via dynamin-dependent endocytosis in endothelial cells in vitro

P2860

Q28386699-75237B9C-1E81-495D-A341-3208130F66D0 Q28654242-D6372EB9-4548-4B00-99A8-11FC5B6D986B Q33961538-BC066779-CC4B-4236-B0AB-0D2C892E707A Q36163874-7D7D838D-A240-4DF4-AE50-945357916620 Q36603426-BA2CEC6C-03C9-4465-A1FD-4E078847A984 Q38234567-EAC53C6B-C002-4802-BBB8-BB08A3F84576 Q38912883-F02EB306-8C47-45E7-84A8-2DFF7E10E59C Q41788172-9F7BABBA-200E-47FE-B33F-4FF109E6AEBF Q46341933-9F4FF226-77E7-4037-B540-B782A0A34C81 Q58791044-EF670F69-3C62-404E-A968-92F66D3AE958

P2860

Tumor microenvironment and nanotherapeutics.

http://www.wikidata.org/entity/Q37632757

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tumor microenvironment and nanotherapeutics.

@en

Tumor microenvironment and nanotherapeutics.

@nl

type

label

Tumor microenvironment and nanotherapeutics.

@en

Tumor microenvironment and nanotherapeutics.

@nl

prefLabel

Tumor microenvironment and nanotherapeutics.

@en

Tumor microenvironment and nanotherapeutics.

@nl

P1433

Q37632757-7CD1D23D-F8ED-4E21-838A-6E39CA819B60

P1476

Q37632757-17546E9C-809B-46E3-ADEE-C68986AA5B53

P2093

Q37632757-64B17D17-C63B-4DAA-B4FC-A50929CC8E13

Q37632757-95114022-B3AB-47B1-8F32-83F5DBDB6DA1

Q37632757-C5D781D7-2903-4FAE-BD70-D01063A84CD7

P2860

Q37632757-040698D8-71E4-4C93-A526-3ABCCE57A1C7

Q37632757-04BA35D8-DF13-43F4-BB8F-F04763F52157

Q37632757-069635C5-2AF3-40FD-AA80-4BBCBDA9A0FC

Q37632757-0B551B00-897F-42A9-A54A-36E31FB6B6E6

Q37632757-11AC1DFE-4B8E-47EC-817A-161056A23218

Q37632757-1A5D872A-3F5B-427C-899F-CF3B35B8C106

Q37632757-1D152A16-8900-47EF-B21B-94EA6ABC796C

Q37632757-1D2A34E7-1B12-4942-AE73-820C14EE281C

Q37632757-1E32052B-E068-4BB0-BBFC-980C4F85046E

Q37632757-1E583E05-58C0-4332-8ACF-3EB39C6C167C

P304

Q37632757-411A3C5B-C614-4E90-8567-FF9B886F31C5

P31

Q37632757-16440C9D-F0DF-4BE6-97C8-2A880AC1EA72

P356

Q37632757-F8ED6B0C-E7E4-4615-A3CE-3040BB8C81CA

P433

Q37632757-A58E92C5-CB1C-4B62-8DDC-453B62E04E7C

P478

Q37632757-1027C08E-120B-4730-9BC2-AE3AE2C0D693

P577

Q37632757-DB7E39D8-37AC-408A-AEE4-35A0C8A194B8

P698

Q37632757-1664BB7B-4828-4B30-A24C-4485E5FAFF05

P932

Q37632757-8147DBCC-4CA1-4826-B8DA-EDB2ADC3EAC7

P356

J.ISSN.2218-676X.2013.08.11

P1433

Translational cancer research

P1476

Tumor microenvironment and nanotherapeutics.

@en

P2093

Amar Jyoti

http://www.w3.org/2001/XMLSchema#string

Meenakshi Upreti

http://www.w3.org/2001/XMLSchema#string

Pallavi Sethi

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Hallmarks of Cancer: The Next Generation

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

Understanding the Warburg effect: the metabolic requirements of cell proliferation

Angiogenesis in cancer and other diseases

Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture

Therapeutic nanoparticles for drug delivery in cancer

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

Hypoxia--a key regulatory factor in tumour growth

Drug resistance and the solid tumor microenvironment

P304

309-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2218-676X.2013.08.11

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24634853

http://www.w3.org/2001/XMLSchema#string

P932

3951160

http://www.w3.org/2001/XMLSchema#string